Daniell, Emily

Daniell, Emily was paid $314K by Medicaid between Nov 2019 and Dec 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.

33Billing provider infoDANIELL, EMILY
EAST PROVIDENCE, RI 02914

33aNPI1134657505assigned 05/31/2017

33bProvider typeAcute Care Nurse Practitioner

28Total paid$314K

24GClaims4,352

24DCodes billed7

24AFirst – last monthNov 2019 – Dec 2024

Compared with peers

Next to other Acute Care Nurse Practitioner providers in Rhode Island

Rank by total paid#2 of 21

Median peer was paid$5K

This provider vs. median62×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	150	$4K
2020	555	$30K
2021	799	$47K
2022	440	$22K
2023	1,425	$160K
2024incomplete	983	$51K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	36%	1,843	1,375	$112K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	19%	883	636	$60K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	17%	332	274	$53K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	16%	627	435	$50K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	7.0%	521	441	$22K
90792	Psychiatric diagnostic evaluation with medical services	5.0%	114	82	$16K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	32	26	$2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.